Quotes Relmada Therapeutics, Inc. OTC Markets
Stocks
RLMD
US75955J4022
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
02:29:51 20/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.115 USD | 0.00% |
|
+8.91% | +139.13% |
| 13/11 | Relmada Therapeutics, Inc., Q3 2026 Earnings Call, Nov 12, 2026 | |
| 13/11 | Relmada Therapeutics Q3 Loss Narrows | MT |
Stock exchange
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
30,46,13,785
Net sales (USD)
0
Free-Float
96.77%
Free-Float capitalization (USD)
29,47,77,750
Indicators
Moving average 5 days
10.85
Moving average 100 days
9.48
Price spread / (MMA5)
+248.31%
Price spread / (MMA100)
+204.33%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +8.91% | - | - | 30Cr | ||
| +0.19% | -2.90% | +56.40% | +69.15% | 6.55TCr | ||
| -0.14% | -1.96% | +8.83% | +89.74% | 5.89TCr | ||
| +0.06% | +0.51% | +26.04% | +87.89% | 5.52TCr | ||
| -1.09% | -3.96% | +12.91% | +112.63% | 4.61TCr | ||
| -2.88% | -7.66% | +15.10% | +21.94% | 4.25TCr | ||
| +3.61% | +3.86% | +22.82% | +46.39% | 3.56TCr | ||
| -0.24% | -9.59% | +126.05% | +633.69% | 3.46TCr | ||
| +0.03% | -1.80% | +82.52% | +57.74% | 3.25TCr | ||
| +20.62% | +22.11% | -29.18% | +485.58% | 2.63TCr | ||
| Average | +2.08% | -2.93% | +35.72% | +178.30% | 4TCr | |
| Weighted average by Cap. | +1.37% | -2.69% | +35.18% | +148.55% |
Historical Quotes: Relmada Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- RLMD Stock
- RLMD Stock
- Quotes Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















